QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine-Reference-Cited by-同舟云学术

QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine

Published:2010-10-08 Issue:3 Volume:15 Page:645-653
ISSN:1381-1991
Container-title:Molecular Diversity
language:en
Short-container-title:Mol Divers

Author:

Pourbasheer Eslam,Riahi Siavash,Ganjali Mohammad Reza,Norouzi Parviz

Publisher

Springer Science and Business Media LLC

Subject

Inorganic Chemistry,Organic Chemistry,Physical and Theoretical Chemistry,Drug Discovery,Molecular Biology,General Medicine,Information Systems,Catalysis

Link

http://link.springer.com/content/pdf/10.1007/s11030-010-9283-0.pdf

Reference48 articles.

1. Ikegashira K, Oka T, Hirashima S, Noji S, Yamanaka H, Hara Y, Adachi T, Tsuruha J-I, Doi S, Hase Y, Noguchi T, Ando I, Ogura N, Ikeda S, Hashimoto H (2006) Discovery of conformationally constrained tetracyclic compounds as potent hepatitis C virus NS5B RNA polymerase inhibitors. J Med Chem 49: 6950–6953. doi: 10.1021/jm0610245

2. Gopalsamy A, Chopra R, Lim K, Ciszewski G, Shi M, Curran KJ, Sukits SF, Svenson K, Bard J, Ellingboe JW, Agarwal A, Krishnamurthy G, Howe AYM, Orlowski M, Feld B, O’Connell J, Mansour TS (2006) Discovery of proline sulfonamides as potent and selective hepatitis C virus NS5b polymerase inhibitors. Evidence for a new NS5b polymerase binding site. J Med Chem 49: 3052–3055. doi: 10.1021/jm060168g

3. Frick DN (2004) The hepatitis C virus replicase: insights into RNA-dependent RNA replication and prospects for rational drug design. Curr Org Chem 8: 223–241. doi: 10.2174/1385272043485963

4. Zhou Y, Webber SE, Murphy DE, Li L-S, Dragovich PS, Tran CV, Sun Z, Ruebsam F, Shah AM, Tsan M, Showalter RE, Patel R, Li B, Zhao Q, Han Q, Hermann T, Kissinger CR, LeBrun L, Sergeeva MV, Kirkovsky L (2008) Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1. Exploration of 7′-substitution of benzothiadiazine. Bioorg Med Chem Lett 18: 1413–1418. doi: 10.1016/j.bmcl.2008.01.007

5. Zhou Y, Li L-S, Dragovich PS, Murphy DE, Tran CV, Ruebsam F, Webber SE, Shah AM, Tsan M, Averill A, Showalter RE, Patel R, Han Q, Zhao Q, Hermann T, Kissinger CR, LeBrun L, Sergeeva MV (2008) Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′ λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 2. Variation of the 2- and 6-pyridazinone substituents. Bioorg Med Chem Lett 18: 1419–1424. doi: 10.1016/j.bmcl.2008.01.005

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Insight into the structural requirement of aryl sulphonamide based gelatinases (MMP-2 and MMP-9) inhibitors – Part I: 2D-QSAR, 3D-QSAR topomer CoMFA and Naïve Bayes studies – First report of 3D-QSAR Topomer CoMFA analysis for MMP-9 inhibitors and jointly inhibitors of gelatinases together;SAR and QSAR in Environmental Research;2021-08-03

2. Structural Relationship Study of Octanol-Water Partition Coefficient of Some Sulfa Drugs Using GA-MLR and GA-ANN Methods;Current Computer-Aided Drug Design;2020-06-02

3. Anti-gastric cancer activity of 1,2,3-triazolo[4,5-d]pyrimidine hybrids (1,2,3-TPH): QSAR and molecular docking approaches;Heliyon;2020-03

4. Prediction of stenosis behaviour in artery by neural network and multiple linear regressions;Biomechanics and Modeling in Mechanobiology;2020-02-03

5. Simultaneous Spectrophotometric Determination of Aspirin and Dipyridamole in Pharmaceutical Formulations Using the Multivariate Calibration Methods;Current Pharmaceutical Analysis;2018-05-03